Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Feb 10, 2015
Insider Transaction Report
Form 4
Brown Christopher Nigel
Director
Transactions
- Conversion
Ordinary Shares
2015-02-10+8,800→ 8,800 total(indirect: By Elsing Pty Ltd) - Conversion
Series A Investment Preference Shaers
2015-02-10−8,800→ 0 total(indirect: By Elsing Pty Ltd)→ Ordinary Shares (8,800 underlying)
Footnotes (2)
- [F1]Reflects automatic conversion of Series A Investment Preference Shares into ordinary shares on a one-for-one basis upon the completion of the initial public offering of Issuer's ordinary shares.
- [F2]The reporting person has sole voting and dispositive power with respect to the reported securities.